UBS maintains its 'buy' recommendation on AB InBev, as well as its target price of 72 euros, implying a 32% upside potential for the stock, ahead of the Belgian brewer's (Stella Artois, Corona, Leffe) second-quarter results.

The broker predicts organic EBITDA growth of +11% for this period (versus +8.6% consensus), driven by potential upside for margin expectations, in particular leverage on general and administrative expenses (SG&A).

Copyright (c) 2024 CercleFinance.com. All rights reserved.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.